Health
New Data Presented at ADA 2025 Highlights Burden and Risk Associations of Cardiac Arrhythmias in Patients with Type 2 Diabetes and Chronic Kidney Disease
Retrospective real-world analyses of patients with type 2 diabetes—some of whom also had chronic kidney disease—demonstrate cardiac arrhythmias present frequent and early, often preceding major cardiovascular events (MACE)SAN FRANCISCO, June 23, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) announced the results from two large-scale real-world studies presented at the American Diabetes Association’s 85th Scientific Sessions (ADA 2025). The analyses reveal that cardiac arrhyth
About this update from Irhythm Holdings, Inc.
[{"type":"image","alt":"iRhythm","displaySize":"","headline":null,"caption":"iRhythm","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":43,"url":"https://media.zenfs.com/en/globenewswire.com/f45ffedb3d05402e7e1d1906344ea62f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/s9HO7ZqpsQD8YOjAXzOofg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTYwO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/f45ffedb3d05402e7e1d1906344ea62f","width":300,"height":43}},"lazy":false},{"type":"text","content":"Retrospective real-world analyses of patients with type 2 diabetes—some of whom also had chronic kidney disease—demonstrate cardiac arrhythmias present frequent and early, often preceding major cardiovascular events (MACE)","length":222,"tagName":"p"},{"type":"text","content":"SAN FRANCISCO, June 23, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) announced the results from two large-scale real-world studies presented at the American Diabetes Association’s 85th Scientific Sessions (ADA 2025). The analyses reveal that cardiac arrhythmias are common and often occur early in people with type 2 diabetes (T2D)—especially those who also have chronic kidney disease (CKD). These findings suggest a critical opportunity to enhance early detection strategies in at-risk cardiometabolic populations.","length":537,"tagName":"p"},{"type":"text","content":"The studies examined longitudinal claims data from over 30 million U.S. adults, providing new insights into how arrhythmias—often asymptomatic—cluster around major disease inflection points. In T2D patients, arrhythmias were frequently identified prior to or shortly after diagnoses of CKD or major adverse cardiovascular events such as stroke or heart failure.","length":361,"tagName":"p"},{"type":"text","content":"Cardiac arrhythmias—conditions in which the heart beats too fast, too slow, or irregularly1—are a serious public health concern. In the general U.S. population, they affect roughly 1 in 20 adults2. But in people with type 2 diabetes and chronic kidney disease—already at elevated cardiovascular risk3—new data reveal that arrhythmias occur more frequently, and often much earlier, than previously recognized.","length":408,"tagName":"p"},{"type":"text","content":"Left undetected, certain arrhythmias can lead to stroke, heart failure, hospitalization, or even death4-6. That’s ...